SRTS
Sensus Healthcare, IncstockNASDAQ
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.41 | 2026-11-11 | -32.99% | -11.477 |
| 1M | 2.76 | 2026-10-19 | -17.21% | 2.174 |
| 3M | 3.00 | 2026-08-18 | -23.83% | 1.651 |
| 6M | 3.47 | 2026-05-18 | -34.15% | 1.013 |
| 1Y | 4.04 | 2025-11-18 | -43.44% | 1.185 |
| 2Y | 8.41 | 2024-11-18 | -72.83% | — |
| 5Y | 5.52 | 2021-11-18 | -58.60% | 0.970 |
Sensus Healthcare, Inc (NASDAQ:SRTS) stock price today is $2.29, and today's volume is 77,189. SRTS is up 1.106% today. The 30 day average volume is 396,702. SRTS market cap is $37.62M with 16.46M shares outstanding.
